Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2013 | ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT | Liu, C. -J.; Wang, C. -C.; Yang, S. -S.; Su, C. -W.; Liao, L. -Y.; Lee, T. -H.; Chuang, W. -L.; Chen, C. -L.; Chien, R. -N.; Peng, C. -Y.; Lee, C. -M.; Lee, Y. -F.; Kao, J. -H.; Chen, P. -J.; Chen, D. -S. | J. Hepatol. | |||
2015 | High anus preservation and low toxicity rates in a phase I trial of neoadjuvant bowel-sparing IMRT/bevacizumab/FOLFOX and TME for locally advanced rectal cancer | Cheng, J. C. -H.; Liang, J. -T.; Tsai, C. -L.; Hung, J. -S.; Huang, J.; Lin, Y. -L.; Wang, C. -C.; 林育麟; 成佳憲; 洪基翔; 梁金銅 | Ann. Oncol. |